|
PANK2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.182500E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.900700E-03 |
| Normal-vs-Stage2 |
2.145500E-02 |
| Normal-vs-Stage3 |
8.719700E-02 |
| Normal-vs-Stage4 |
1.457580E-02 |
| Stage1-vs-Stage2 |
5.519600E-01 |
| Stage1-vs-Stage3 |
2.940200E-01 |
| Stage1-vs-Stage4 |
9.755200E-01 |
| Stage2-vs-Stage3 |
6.369400E-01 |
| Stage2-vs-Stage4 |
6.701000E-01 |
| Stage3-vs-Stage4 |
4.220200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.955600E-03 |
| Normal-vs-AfricanAmerican |
4.221700E-03 |
| Normal-vs-Asian |
3.256200E-01 |
| Caucasian-vs-AfricanAmerican |
3.832000E-01 |
| Caucasian-vs-Asian |
2.508000E-01 |
| AfricanAmerican-vs-Asian |
1.338990E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.296700E-03 |
| Normal-vs-Female |
1.407780E-01 |
| Male-vs-Female |
4.630600E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.499600E-02 |
| Normal-vs-Extreme_Weight |
1.219750E-03 |
| Normal-vs-Obese |
1.236480E-02 |
| Normal-vs-Extreme_Obese |
2.098400E-03 |
| Normal_Weight-vs-Extreme_Weight |
1.108220E-01 |
| Normal_Weight-vs-Obese |
9.362000E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.138610E-01 |
| Extreme_Weight-vs-Obese |
1.340160E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.391400E-01 |
| Obese-vs-Extreme_Obese |
1.493830E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.896380E-01 |
| Normal-vs-Age(41-60Yrs) |
2.028500E-02 |
| Normal-vs-Age(61-80Yrs) |
3.535400E-03 |
| Normal-vs-Age(81-100Yrs) |
5.038700E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.290400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.890300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.555900E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.035170E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.715900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.187230E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.895000E-03 |
| Normal-VS-Type2 PRCC |
1.780730E-03 |
| Normal-VS-KIRP CIMP |
8.652800E-01 |
| Normal-VS-Unclassified PRCC |
4.769200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.961400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.422200E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
4.183800E-03 |
| Type2 PRCC-VS-KIRP CIMP |
3.636300E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
7.993200E-04 |
| KIRP CIMP-VS-Unclassified PRCC |
6.623200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.995300E-03 |
| Normal-vs-N1 |
1.793620E-01 |
| Normal-vs-N2 |
3.254200E-01 |
| N0-vs-N1 |
3.592200E-02 |
| N0-vs-N2 |
6.507800E-01 |
| N1-vs-N2 |
5.472200E-01 |
|
|
